This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Medco CEO: Healthcare Innovation Is Essential For Sustainable Reform And A Core Component Of Any Plan For Long-Term U.S. Financial Solvency

Stocks in this article: MHS

The positive impact of a fully wired system would be profound.  "Gaps in care," largely the result of medications that are underprescribed, misprescribed or not taken as directed by a physician, lead to unnecessary hospitalization, emergency room visits, and extended illnesses.  A fully wired system, Snow argued, ensures the most appropriate, targeted information is available to both physicians and patients

The results of such enhanced physician and patient insight would be substantial: significantly increased safety, improved outcomes and hundreds of billions in annual savings.  Indeed, the poor management of chronic and complex disease alone costs the U.S. an estimated $350 billion a year.  

Snow pointed out that in combination with other reforms – including medical malpractice reform; restoring the financial solvency of Medicare; and the systematic promotion and incentivizing of healthy lifestyles – the U.S. could achieve as much as $1 trillion a year in healthcare cost reduction.

Snow, who has more than 30 years of experience managing hospitals and healthcare systems and himself comes from a family of physicians, went on to make a detailed case that integrating all facets of medical/scientific knowledge through a wired platform could finally realize the oft-cited healthcare ideal: getting the right treatment to the right patient at the right time – all the time.  

Medco's specialized expertise in the practice of pharmacy, combined with evidence-based research gathered through its Medco Research Institute, provides the knowledge, precision and efficiency that, applied system-wide, could move U.S. healthcare practice from what amounts to "shotgun medicine" today to precision medicine tomorrow, improving patient outcomes and bending down the cost curve.  

However, ultimate success will hinge, Snow cautioned, on the extent to which the effort is underpinned by an enlightened public-private partnership in which the government drives strategic foundational policies and regulations and the private sector, fueled by fair competition, is motivated to innovate.

2 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,678.70 +6.10 0.03%
S&P 500 2,057.09 +5.27 0.26%
NASDAQ 4,771.7630 +13.8840 0.29%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs